BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boccara F, Teiger E, Cohen A, Ederhy S, Janower S, Odi G, Di Angelantonio E, Barbarini G, Barbaro G. Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis. Heart. 2006;92:543-544. [PMID: 16537777 DOI: 10.1136/hrt.2005.068445] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Martín-Reyes R, Galeote G, Moreno R, Sánchez-Recalde A, López De Sá E, López-Sendón JL. [Percutaneous coronary intervention in HIV infected patients with human immunodeficiency virus admitted with acute coronary syndrome: case-control study]. Med Clin (Barc) 2010;135:691-4. [PMID: 20599234 DOI: 10.1016/j.medcli.2010.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Mavroudis CA, Majumder B, Loizides S, Christophides T, Johnson M, Rakhit RD. Coronary artery disease and HIV; getting to the HAART of the matter. International Journal of Cardiology 2013;167:1147-53. [DOI: 10.1016/j.ijcard.2012.09.043] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
3 Mishra RK. Cardiac emergencies in patients with HIV. Emerg Med Clin North Am 2010;28:273-82, Table of Contents. [PMID: 20413011 DOI: 10.1016/j.emc.2010.01.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
4 Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, Capeau J, Cohen A. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol. 2013;61:511-523. [PMID: 23369416 DOI: 10.1016/j.jacc.2012.06.063] [Cited by in Crossref: 181] [Cited by in F6Publishing: 167] [Article Influence: 20.1] [Reference Citation Analysis]
5 Lipshultz SE, Miller TL, Wilkinson JD, Scott GB, Somarriba G, Cochran TR, Fisher SD. Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America. J Int AIDS Soc. 2013;16:18597. [PMID: 23782480 DOI: 10.7448/ias.16.1.18597] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
6 Bundhun PK, Pursun M, Huang WQ. Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis. BMC Cardiovasc Disord 2017;17:190. [PMID: 28716008 DOI: 10.1186/s12872-017-0624-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
7 Boccara F. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors. AIDS 2008;22 Suppl 3:S19-26. [PMID: 18845918 DOI: 10.1097/01.aids.0000327512.76126.6e] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
8 Monsuez J, Charniot J, Escaut L, Teicher E, Wyplosz B, Couzigou C, Vignat N, Vittecoq D. HIV-associated vascular diseases: Structural and functional changes, clinical implications. International Journal of Cardiology 2009;133:293-306. [DOI: 10.1016/j.ijcard.2008.11.113] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
9 Liu Y, Chen Y, Hao Y, Xiao J, Li B, Zhang L, Han J, Zhao H, Nguyen TN. Assessment of Clinical Features in HIV-Infected Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in China. Journal of Interventional Cardiology 2022;2022:1-8. [DOI: 10.1155/2022/8351304] [Reference Citation Analysis]
10 Triant VA, Grinspoon SK. Vascular dysfunction and cardiovascular complications. Curr Opin HIV AIDS 2007;2:299-304. [PMID: 19372902 DOI: 10.1097/COH.0b013e3281e7e831] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
11 Ballocca F, D'Ascenzo F, Gili S, Grosso Marra W, Gaita F. Cardiovascular disease in patients with HIV. Trends Cardiovasc Med 2017;27:558-63. [PMID: 28779949 DOI: 10.1016/j.tcm.2017.06.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
12 Dau B, Holodniy M. The Relationship Between HIV Infection and Cardiovascular Disease. Curr Cardiol Rev 2008;4:203-18. [PMID: 19936197 DOI: 10.2174/157340308785160589] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
13 Peyracchia M, Verardi R, Rubin SR, Abu-Assi E, Montrucchio C, Perl L, Grossomarra W, Calcagno A, Omedè P, Montefusco A, Bonora S, Moretti C, D'Amico M, Mauro R, D'Ascenzo F. In-hospital and long-term outcomes of HIV-positive patients undergoing PCI according to kind of stent: a meta-analysis. J Cardiovasc Med (Hagerstown) 2019;20:321-6. [PMID: 30664538 DOI: 10.2459/JCM.0000000000000767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
14 Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, Grinspoon SK, Levin J, Longenecker CT, Post WS. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation 2019;140:e98-e124. [PMID: 31154814 DOI: 10.1161/CIR.0000000000000695] [Cited by in Crossref: 123] [Cited by in F6Publishing: 66] [Article Influence: 41.0] [Reference Citation Analysis]
15 d'Ettorre G, Ceccarelli G, Pavone P, Vittozzi P, De Girolamo G, Schietroma I, Serafino S, Giustini N, Vullo V. What happens to cardiovascular system behind the undetectable level of HIV viremia? AIDS Res Ther 2016;13:21. [PMID: 27127532 DOI: 10.1186/s12981-016-0105-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
16 Feinstein MJ, Poole B, Engel Gonzalez P, Pawlowski AE, Schneider D, Provias TS, Palella FJ, Achenbach CJ, Lloyd-Jones DM. Differences by HIV serostatus in coronary artery disease severity and likelihood of percutaneous coronary intervention following stress testing. J Nucl Cardiol 2018;25:872-83. [PMID: 27739037 DOI: 10.1007/s12350-016-0689-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
17 Alkhalil M, Conlon CP, Ashrafian H, Choudhury RP. Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection. World J Clin Cases 2017; 5(2): 40-45 [PMID: 28255546 DOI: 10.12998/wjcc.v5.i2.40] [Reference Citation Analysis]
18 D'Ascenzo F, Cerrato E, Appleton D, Moretti C, Calcagno A, Abouzaki N, Vetrovec G, Lhermusier T, Carrie D, Das Neves B, Escaned J, Cassese S, Kastrati A, Chinaglia A, Belli R, Capodanno D, Tamburino C, Santilli F, Parodi G, Vachiat A, Manga P, Vignali L, Mancone M, Sardella G, Fedele F, DiNicolantonio JJ, Omedè P, Bonora S, Gaita F, Abbate A, Zoccai GB; Percutaneous coronary intervention and surgical revascularization in HIV Database (PHD) Study Investigators. Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States. Thromb Res 2014;134:558-64. [PMID: 25064035 DOI: 10.1016/j.thromres.2014.05.037] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
19 McCutcheon K, Triantafyllis AS, Van den Eynde J, Oosterlinck W, Vachiat A, Tsabedze N, Zachariah D, Manga P, Bennett J. Coronary revascularization in patients with HIV. Trends Cardiovasc Med 2021:S1050-1738(21)00027-X. [PMID: 33626383 DOI: 10.1016/j.tcm.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Bernelli C, Danzi GB, Cerrato E, Pierini S, Ornaghi MG, Botta L, Gentile F, Migliorino GM, Squillace N. Cardiovascular Events Recurrence and Coronary Artery Disease in HIV Patients: The Price We Have to Pay for the Chronicization of the Disease. Can J Cardiol 2020;36:127-34. [PMID: 31813674 DOI: 10.1016/j.cjca.2019.07.636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Martin A, Emery S. Metabolic disorders and cardiovascular consequences of  HIV infection and antiretroviral  therapy. Expert Rev Clin Pharmacol 2009;2:381-90. [PMID: 22112182 DOI: 10.1586/ecp.09.11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
22 Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J. 2011;32:41-50. [PMID: 20965887 DOI: 10.1093/eurheartj/ehq372] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
23 Tsabedze N, Vachiat A, Zachariah D, Manga P. A New Face of Cardiac Emergencies: Human Immunodeficiency Virus-Related Cardiac Disease. Cardiol Clin 2018;36:161-70. [PMID: 29173676 DOI: 10.1016/j.ccl.2017.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
24 Carballo D, Delhumeau C, Carballo S, Bähler C, Radovanovic D, Hirschel B, Clerc O, Bernasconi E, Fasel D, Schmid P, Cusini A, Fehr J, Erne P, Keller PF, Ledergerber B, Calmy A; Swiss HIV Cohort Study and AMIS registry. Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study. AIDS Res Ther 2015;12:4. [PMID: 25705241 DOI: 10.1186/s12981-015-0045-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ceccarelli G, d'Ettorre G, Mancone M, Francone M, Vullo V. Accelerated coronary atherosclerosis after execution of percutaneous coronary intervention in patient with HIV/HCV coinfection: case report and review of the literature. Cardiovasc Revasc Med 2011;12:262-5. [PMID: 21273145 DOI: 10.1016/j.carrev.2010.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
26 Beltrán LM, Rubio-Navarro A, Amaro-Villalobos JM, Egido J, García-Puig J, Moreno JA. Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus. Vasc Health Risk Manag 2015;11:35-48. [PMID: 25609975 DOI: 10.2147/VHRM.S65885] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
27 Boccara F. Acute coronary syndrome in HIV-infected patients. Does it differ from that in the general population? Arch Cardiovasc Dis 2010;103:567-9. [PMID: 21147440 DOI: 10.1016/j.acvd.2010.10.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
28 Badr S, Minha S, Kitabata H, Fatemi O, Torguson R, Suddath WO, Satler LF, Pichard AD, Waksman R. Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus: PCI in Patients with HIV. Cathet Cardiovasc Intervent 2015;85:192-8. [DOI: 10.1002/ccd.25466] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
29 Shah MR, Cook N, Wong R, Hsue P, Ridker P, Currier J, Shurin S. Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease. J Am Coll Cardiol 2015;65:738-44. [PMID: 25677433 DOI: 10.1016/j.jacc.2014.12.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
30 Demir OM, Candilio L, Fuster D, Muga R, Barbaro G, Colombo A, Azzalini L. Cardiovascular disease burden among human immunodeficiency virus-infected individuals. Int J Cardiol 2018;265:195-203. [PMID: 29885686 DOI: 10.1016/j.ijcard.2018.03.137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
31 Vachiat A, Mccutcheon K, Tsabedze N, Zachariah D, Manga P. HIV and Ischemic Heart Disease. Journal of the American College of Cardiology 2017;69:73-82. [DOI: 10.1016/j.jacc.2016.09.979] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
32 Parks MM, Secemsky EA, Yeh RW, Shen C, Choi E, Kazi DS, Hsue PY. Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection. Eur Heart J Qual Care Clin Outcomes 2021;7:273-9. [PMID: 33226071 DOI: 10.1093/ehjqcco/qcaa088] [Reference Citation Analysis]
33 Carvalho AS, Osório Valente R, Almeida Morais L, Modas Daniel P, Sá Carvalho R, Ferreira L, Cruz Ferreira R. HIV and coronary disease - When secondary prevention is insufficient. Rev Port Cardiol 2017;36:569.e1-8. [PMID: 28697899 DOI: 10.1016/j.repc.2016.10.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
34 Fisher SD, Kanda BS, Miller TL, Lipshultz SE. Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients: . American Journal Cardiovascular Drugs 2011;11:383-94. [DOI: 10.2165/11594590-000000000-00000] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
35 D’Ascenzo F, Cerrato E, Biondi-Zoccai G, Moretti C, Omedè P, Sciuto F, Bollati M, Modena MG, Gaita F, Sheiban I. Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J. 2012;33:875-880. [PMID: 22187508 DOI: 10.1093/eurheartj/ehr456] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 7.0] [Reference Citation Analysis]
36 Albaeni A, Harris C, Eid SM, Abougergi MS, Wright SM. HIV status and type of coronary stent placed in patients presenting with ST-elevation myocardial infarction. Coron Artery Dis 2017;28:239-45. [PMID: 28288008 DOI: 10.1097/MCA.0000000000000488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]